Join Our Newsletter
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
Groundbreaking research reveals that cancer cells exploit nerve pathways to suppress immune defenses. The study uncovers how the ATF4–SLIT2–CGRP axis triggers pain, weakens immunity, and reduces immunotherapy effectiveness — offering new hope for innovative cancer treatments.
A groundbreaking Nature study shows that COVID-19 mRNA vaccines may enhance cancer immunotherapy by unleashing powerful immune responses, turning resistant tumors into treatment-ready targets — a discovery that could transform oncology forever.
Discover the latest cancer research breakthroughs from Memorial Sloan Kettering (MSK) presented at ESMO 2025, including new therapies for lung, pancreatic, and mismatch repair–deficient solid tumors. Explore the promising clinical results that may redefine future cancer care.
New research reveals a dual-targeting approach that inhibits LOX and HSP70 — key drivers of extracellular matrix remodeling — to suppress melanoma metastasis and enhance immunotherapy response.